Correction to Amgen 3Q Earnings Review

Date : 10/29/2019 @ 10:51PM
Source : Dow Jones News
Stock : Amgen Inc (AMGN)
Quote : 230.65  -4.39 (-1.87%) @ 2:50PM

Correction to Amgen 3Q Earnings Review

Amgen (NASDAQ:AMGN)
Historical Stock Chart

3 Months : From Oct 2019 to Jan 2020

Click Here for more Amgen Charts.

Starting next year, Amgen Inc. will list Repatha for $5,850 a year for all insurers. It rolled out at that price last year, but still supplied the treatment at the original price of more than $14,000 in some cases. "Amgen Posts Stronger-than-Expected 3Q Results -- Earnings Review" at 16:18 p.m. ET, incorrectly stated that $5,850 was 60% lower than the current price.

 

(END) Dow Jones Newswires

October 29, 2019 18:36 ET (22:36 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest AMGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.